At #STATBreakthrough, we asked speakers and attendees what the last scientific breakthrough that stopped you in your tracks?
Their answers:
At the #STATBreakthrough Summit, we asked speakers and attendees if The White House asked them for one policy idea, what would you tell them?
Their answers:
Discussions on social media are both more important and more contentious than ever, Dr. Noc offered his advice with dealing with negative comments online.
#STATBreakthrough
At #STATBreakthrough, Seng Cheng, senior vice president of research & product development at Alexion talks about why drugmakers want to do clinical trials in China.
Jacob Van Naarden was CEO of Loxo Oncology before if got acquired by Lilly. Now, as president of Lilly Oncology and head of corporate business development, he looks at almost a dozen biopharma deals a week.
#STATBreakthrough
STAT executive editor @rickberke.bsky.social asks HHS chief counselor and Medicare director Chris Klomp his secret to success and popularity in this administration.
#STATBreakthrough
Sharon Mates brought a schizophrenia drug to market in 2020, here’s how she made the case for that drug despite some conflicting studies on its efficacy.
#STATBreakthrough
On our “The Influencer’s Dilemma” panel, science communicators talked not only about the problems with science content on social media but also the potential of those platforms.
#STATBreakthrough
Former FDA Commissioner Robert Califf had a lot to say at #STATBreakthrough, including on how politics have affected the operations of the FDA.
At #STATBreakthrough, Medicare head Chris Klomp got fired up about patient record ownership, data blocking, telehealth, site neutral, and more. Listen:
“The role of government, in my view, is to step in when markets fail,” HHS' Chris Klomp says at #STATBreakthrough.
www.statnews.com/2026/03/19/c...
STAT's Mario Aguilar asks Chris Klomp about the next CDC director. #STATBreakthrough
STAT FDA reporter @lizzylawrence.bsky.social asks HHS chief counselor Chris Klomp about the turnover at the FDA.
Klomp: “When I see turnover in any organization — could be the FDA, it could be another — it's worrisome…”
#STATBreakthrough
Michel Sadelain, director at the Columbia Initiative in Cell Engineering and Therapy, talks about people’s expectations for the business of CAR-T therapy and how far the science has come.
#STATBreakthrough
At #STATBreakthrough, Biogen and Bristol Myers Squibb R&D leaders behind blockbuster drugs talk about what they see on the horizon, including more competition from China.
There are things we will never do as a country that China will.
Chris Klomp when talking about clinical trials. #STATBreakthrough
two men sit on the summit stage
Now time for: Medicare’s High-Tech Cost-Cutter
Hear how Chris Klomp insisted on bargain-priced flights and boasted of sleeping in rental cars and crummy motels plans to use technology to cut costs in the U.S. government’s health insurance program for older Americans. #STATBreakthrough
"There's three times more PhDs that have been given last year in China than in the US. ... That's a lot of bright young things [people] out there who are going to be thinking about the next thing in front of them, because that's what we do as scientists."
As concerns swirl about the U.S. ceding supremacy in biomedical research, Biogen's Jane Grogan highlights the fact that China is producing many more researchers.
#STATBreakthrough
"It's an overnight sensation a decade in the making. These things can actually be going on for a very long time, and then suddenly the field catches up."
The success of some drugs can seem to come out of the blue, but @bristolmyerssquibb.bsky.social's Robert Plenge, at our "During our How To Spot a Blockbuster" panel, said such discoveries, like GLP-1s are years in the making. #STATBreakthrough
three people sit on the summit stage
Our first panel: How To Spot a Blockbuster
Two executives, who lead research at some of the world’s most innovative drugmakers, explain how they separate promising ideas from blind alleys in the search for novel treatments.
#STATBreakthrough
an empty stage with three open chairs
It's #STATBreakthrough East Summit Day!
We're here in NYC, an hour away from today's programing, and we're excited to get underway!
Make sure to follow along for live updates!
Virtual passes still available: www.statnews.com/stat-summit-...
An image showing the details of a conversation between Rob Califf and Lizzy Lawrence
An image showing the details of a conversation between Chris Klomp and Mario Aguilar
Many interesting conversations ahead today at #STATBreakthrough — including on CMS and FDA, both at critical junctures:
Featured Session: The Influencer's Dilemma
These experts have huge audiences. They fact-check health claims online and combat misconceptions about everything from nutrition to vaccines to how science is done. We ask: how can we best engage with conspiracies and medical skepticism?
Join us: www.statnews.com/stat-summit-...
#STATBreakthrough
Check out our post on X for a chance to win a free ticket to our #STATBreakthrough Summit East!
x.com/statnews/sta...
Featured Session: Medicare's High-Tech Cost-Cutter. 2026 Breakthrough Summit East
Thursday, STAT's @mariojoze.bsky.social will sit down with the Director of Medicare, Chris Klomp, to talk about Medicare's high-tech cost-cutter, and much more.
#STATBreakthrough full agenda and tickets here: www.statnews.com/stat-summit-...
Get 40% off virtual passes with promo code: LASTCALL-40
Featured Session: The Influencer's Dilemma with 5 headshots and titles underneath.
We're excited to have Darien Sutton joining our "The Influencer's Dilemma" panel at our #STATBreakthrough Summit East in NYC!
Learn more about the event and get tickets here: www.statnews.com/stat-summit-...
At #STATBreakthrough Summit East in NYC on March 19, Dr. Jessica Knurick and her fellow science communicators will take on one of the biggest challenges in public health today: how to respond effectively to online misinformation and medical skepticism.
Join us: www.statnews.com/stat-summit-...
At #STATBreakthrough Summit West, SBS spoke with Boston Scientific’s CMO about 3 AI use cases in cardiology — from scaling ECG data to spotting heart failure early.
We also discussed the intersection of evidence-based medicine and AI:
www.statnews.com/sponsor/2025...
@statnews.com #cardiology
What do some of the top thinkers in biotech and healthcare hope for the next ten years?
#STATBreakthrough
UnitedHealth said it was too dangerous for him to be discharged. Days later, it denied his care
By @angusrohan.bsky.social , on @caseyross.bsky.social 's amazing #STATBreakthrough panel.
www.statnews.com/2025/05/19/u...